MYL

Mylan NL
NASDAQ

Real-time Quotes | Nasdaq Last Sale

17.62
+0.55
+3.22%
Closed 18:12 06/01 EDT
OPEN
17.01
PREV CLOSE
17.07
HIGH
17.83
LOW
17.00
VOLUME
6.11M
TURNOVER
--
52 WEEK HIGH
23.11
52 WEEK LOW
12.75
MARKET CAP
9.11B
P/E (TTM)
146.22
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 17 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average MYL stock price target is 22.07 with a high estimate of 29.00 and a low estimate of 17.00.

EPS

MYL News

More
Revance, Mylan Move Forward With Botox Rival; Analyst Sees Long Path Ahead
SmarterAnalyst · 2h ago
Avidity Biosciences Starts U.S. IPO Plan
Seeking Alpha - Article · 15h ago
Pfizer Is Charging Ahead With A Coronavirus Vaccine Is PFE Stock A Buy?
Investor's Business Daily · 21h ago
Revance and Mylan to Advance Development Program for Biosimilar to BOTOX®
Business Wire · 21h ago
Revance And Mylan To Advance Development Program For Biosimilar To BOTOX; $30M Milestone Payable To Revance From Mylan
Benzinga · 22h ago
Mylan��s Pakistan Partner to Sell Covid-19 Drug Within Two Months
bloomberg.com · 1d ago
Is Pfizer a Great Dividend Stock?
MotleyFool.com · 3d ago
Mylan Invalidates Sanofi's Lantus® SoloSTAR® Device Patents in IPR Proceedings
PR Newswire · 3d ago

Industry

Pharmaceuticals
-1.07%
Pharmaceuticals & Medical Research
-0.77%

Hot Stocks

Symbol
Price
%Change

About MYL

Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic, brand name and over-the-counter (OTC) products in a range of dosage forms and therapeutic categories. It operates through three segments on a geographic basis, North America, Europe and Rest of World. The Company's Cold-EEZE family of brands includes OTC cold remedies sold as lozenges, gummies, oral sprays, caplets, QuickMelts and oral liquid dose forms in the United States. The North America segment primarily develops, manufactures, sells and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream or ointment form. The Europe segment sells pharmaceuticals under their International Nonproprietary Name (INN), such as active pharmaceutical ingredient (API), in certain European countries. The Rest of World segment is primarily made up of its operations in India, Australia, Japan and New Zealand.
More

Webull offers kinds of Mylan NV stock information, including NASDAQ:MYL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MYL stock news, and many more online research tools to help you make informed decisions.